1.
|
Details of PDMR/person closely associated with them
(‘PCA’)
|
||
a)
|
Name
|
Mr P Thomson
|
|
b)
|
Position/status
|
President, Global Affairs
|
|
c)
|
Initial
notification/ amendment
|
Initial notification
|
|
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
||
a)
|
Name
|
GlaxoSmithKline plc
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
||
a)
|
Description
of the financial instrument
|
Ordinary shares of 25 pence each (‘Ordinary
Shares’)
ISIN: GB0009252882
|
|
b)
|
Nature
of the transaction
|
Acquisition
of Ordinary Shares following the exercise of options granted on 30
November 2016 at the option price of £12.95 per Ordinary Share
under the Company’s ShareSave Plan.
|
|
c)
|
Price(s)
and volume(s)
|
Price(s)
|
Volume(s)
|
£12.95
|
277
|
||
d)
|
Aggregated
information
Aggregated
volume Price
|
N/A (single transaction)
|
|
e)
|
Date
of the transaction
|
2020-06-12
|
|
f)
|
Place
of the transaction
|
London Stock Exchange (XLON)
|
|
GlaxoSmithKline plc
|
|
(Registrant)
|
|
|
Date: June
16, 2020
|
|
|
|
|
By:/s/ VICTORIA
WHYTE
--------------------------
|
|
|
|
Victoria Whyte
|
|
Authorised
Signatory for and on
|
|
behalf
of GlaxoSmithKline plc
|